Indaptus Therapeutics (INDP) EPS (Basic) (2020 - 2026)
Indaptus Therapeutics (INDP) posted quarterly EPS (Basic) of -$0.2 for Q1 2026, up 97.78% year-over-year from -$0.1 in Q1 2025, and up 97.61% quarter-over-quarter from -$8.47 in Q4 2025.
Indaptus Therapeutics (INDP) EPS (Basic) (2020 - 2026) Analysis & Trends
Indaptus Therapeutics' EPS (Basic) history runs 7 years deep, the most recent figure standing at -$0.2 for Q1 2026.
- In Q1 2026, EPS (Basic) rose 97.78% year-over-year to -$0.2; the TTM figure through Mar 2026 stood at -$1.67 (up 94.89% YoY), while the FY2025 annual figure was -$83.4, up 61.47% from the prior year.
- EPS (Basic) for Q1 2026 stood at -$0.2, up from -$8.47 in the prior quarter.
- The five-year high for EPS (Basic) was -$0.2 in Q1 2026, with the low at -$16.0 in Q3 2023.
- The 5-year median for EPS (Basic) is -$12.05 (2023), against an average of -$11.04.
- The sharpest annual moves came in 2022 and 2023: EPS (Basic) surged 99.99% in 2022, then sank 34.55% in 2023.
- Indaptus Therapeutics' EPS (Basic) stood at -$13.31 in 2022, then decreased by 5.27% to -$14.02 in 2023, then grew by 10.36% to -$12.56 in 2024, then soared by 32.61% to -$8.47 in 2025, then surged by 97.61% to -$0.2 in 2026.
- Business Quant data shows INDP's EPS (Basic) at -$0.2 in Q1 2026, -$8.47 in Q4 2025, and -$2.67 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Basic) (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | 4.34 |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | 12.62 |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | 7.59 |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | -1.96 |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | 2.12 |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | 1.23 |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | -0.72 |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | -0.06 |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | 0.18 |
| 10 | Indaptus Therapeutics | 146.91 Mn | 135.35 Mn | - | -0.02 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -0.02 |
| Mar 31, 2026 | -0.20 |
| Dec 31, 2025 | -8.47 |
| Sep 30, 2025 | -2.67 |
| Jun 30, 2025 | -9.14 |
| Mar 31, 2025 | -9.13 |
| Dec 31, 2024 | -12.56 |
| Sep 30, 2024 | -9.58 |
| Jun 30, 2024 | -14.48 |
| Mar 31, 2024 | -14.46 |
| Dec 31, 2023 | -14.02 |
| Sep 30, 2023 | -16.00 |
| Jun 30, 2023 | -12.05 |
| Mar 31, 2023 | -14.23 |
| Dec 31, 2022 | -13.31 |
| Sep 30, 2022 | -11.89 |
| Jun 30, 2022 | -13.62 |
| Mar 31, 2022 | -11.90 |
| Dec 31, 2021 | -22.19 |
| Sep 30, 2021 | -29.43 |